The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 28, 2022
Filed:
Aug. 25, 2017
Applicant:
Ngm Biopharmaceuticals, Inc., South San Francisco, CA (US);
Assignee:
NGM Biopharmaceuticals, Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 39/395 (2006.01); A61K 31/14 (2006.01); C07K 16/28 (2006.01); A61K 31/519 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); C12Q 1/6851 (2018.01); C12Q 1/686 (2018.01); C12Q 1/6886 (2018.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 9/0019 (2013.01); A61K 31/14 (2013.01); A61K 31/519 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01); C12Q 1/686 (2013.01); C12Q 1/6851 (2013.01); C12Q 1/6886 (2013.01); A61K 2039/505 (2013.01); A61K 2039/844 (2018.08); G01N 2800/52 (2013.01);
Abstract
Provided are methods of treating a FGF19-mediated cancer or tumor in a subject by administering to the subject an anti-IL-6 antibody or an anti-IL-6 receptor antibody or an inhibitor of STAT3/JAK signaling pathway, and pharmaceutical compositions relating thereto.